Odd ratio of developing kidney failure figure 1

Slides:



Advertisements
Similar presentations
Chapter 7: Pediatric ESRD 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Advertisements

Chapter 4: Hospitalization 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 2: Healthy People A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 12: USRDS Special Study Center on Transition of Care in CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
Chapter 2: Identification and Care of Patients With CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
Vol 2 Figure 1.1 Trends in the number of incident cases of ESRD, in thousands, by modality, in the U.S. population, Data Source: Reference.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
Chapter 5: Mortality 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Healthy People 2010 Focus Area 4
USRDS 1998 II , ,515 74,116 51,762 Period Prev. Point Prev. Incidence Deaths LFU** Counts (1000s) Year *Preliminary **Lost-to-Followup Reported.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 8: Pediatric ESRD.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 6: Mortality.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 10: Dialysis Providers.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 5: Hospitalization.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 2: Healthy People 2020.
Summary of the 2013 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2015.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 4: Vascular Access.
USRDS USRDS 2002 adr Period prevalent ESRD patient, deaths, & ESRD expenditures figure 12.1.
USRDS 2000 ADR USRDS Hepatitis B vaccine & antibody among patients & unit staff figure 9.1, dialysis patients, 1997, by network.
USRDS USRDS 2002 adr Incident counts by initial modality figure 7.1 patients age 19 years & younger.
USRDS 2000 ADR USRDS Cadaveric donations by gender & race figure 7.1, patients aged
Primary Cause of Kidney Failure in new ESRD patients at initiation, by ethnicity figure 2.1, combined.
2016 Annual Data Report, Vol 2, ESRD, Ch 5
2016 Annual Data Report, Vol 2, ESRD, Ch 8
Section 1: CKD Epidemiology
South African Renal Registry Data as at 31 December 2015
2016 Annual Data Report, Vol 2, ESRD, Ch 6
Healthy People 2010 targets & levels achieved in 2000 figure hp.1
Characteristics of patients Without renal recovery
Figure 10.1 Dialysis unit counts, by unit affiliation, 2011–2014
First-year death rates by modality figure 8
Percent of patients receiving influenza vaccinations figure 5
Patient populations by study group figure 10
ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.
Chapter 2: Identification and Care of Patients With CKD
Mortality rates in incident ESRD patients figure 9
Volume 2: End-Stage Renal Disease
2016 Annual Data Report, Vol 1, CKD, Ch 2
2017 Annual Data Report Healthy People 2020.
Summary of the 2013 ERA-EDTA Registry Annual Report
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
Volume 2: End-Stage Renal Disease
Number of transplants, by donor type figure 8.1
Chapter 7: ESRD among Children, Adolescents, and Young Adults
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
December 31st point prevalent counts by modality figure 3.1
UK Renal Registry 18th Annual Report
2016 Annual Data Report, Vol 2, ESRD, Ch 4
Hospital admissions per patient, by modality figure 5
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
Chapter 6: CKD among Children and Adolescents
Hemoglobin, EPO, & Iron dose figure 4
2018 Annual Data Report Volume 3: Healthy People 2020
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
Volume 2: End-Stage Renal Disease
Volume 2: End-Stage Renal Disease
Chapter 2: Identification and Care of Patients with CKD
Fig 6.1 Frequency of ischaemic heart disease in incident patients
UK Renal Registry 16th Annual Report
Reported ESRD Period and Point Prevalence,
UK Renal Registry 16th Annual Report
UK Renal Registry 15th Annual Report
American Journal of Kidney Diseases
UK Renal Registry 16th Annual Report
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Worldwide incidence of ESRD figure 12.1, per million population
Attributed cause of end-stage renal disease (ESRD) among 251 patients with SLE in the Georgia Lupus Registry who progressed to ESRD (1979–2012), overall.
Presence of inpatient diagnostic codes for attributed cause of end-stage renal disease (ESRD) among 46 patients with systemic lupus erythematosus (SLE)
Chapter 2: Identification and Care of Patients with CKD
Presentation transcript:

Odd ratio of developing kidney failure figure 1 Odd ratio of developing kidney failure figure 1.1, incident ESRD patients, 2000, adjusted for age, gender, & race Odds ratio 1.022+ (1.076) 0.961 to <1.022 0.894 to <0.961 0.791 to <0.894 below 0.791 (0.712)

Incident rates figure 1.2, ESRD patients, 2000, by HSA, smoothed & adjusted for age, gender, & Hispanic ethnicity Rate per million population 383+ (481) 316 to <383 268 to <316 236 to <268 below 236 (206)

Prevalent rates figure 1 Prevalent rates figure 1.3, ESRD patients, 2000, by HSA, smoothed & adjusted for age, gender, & Hispanic ethnicity Rate per million population 1,450+ (1,892) 1,200 to <1,450 1,050 to <1,200 940 to <1,050 below 940 (844)

Incident patients: counts table 1.a, by modality, 2000

Incident patients: counts table 1.a, by modality, 2000 (cont.)

Incident patients: rates table 1.b, by modality, 2000

Incident patients: rates table 1.b, by modality, 2000 (cont.)

Trends in incident rates & annual percent change figure 1 Trends in incident rates & annual percent change figure 1.4, rates adjusted for age, gender, & race Symbols: D% from previous year

Prevalent patient counts, by modality, 2000 table 1 Prevalent patient counts, by modality, 2000 table 1.c, December 31 point prevalent patients

Prevalent patient counts, by modality, 2000 table 1 Prevalent patient counts, by modality, 2000 table 1.c, December 31 point prevalent patients (cont.)

Prevalent patient counts, by modality, 2000 table 1 Prevalent patient counts, by modality, 2000 table 1.d, December 31 point prevalent patients

Prevalent patient counts, by modality, 2000 table 1 Prevalent patient counts, by modality, 2000 table 1.d, December 31 point prevalent patients (cont.)

Trends in prevalent rates & annual % change figure 1 Trends in prevalent rates & annual % change figure 1.5, December 31 point prevalent patients; rates adjusted for age, gender, & race Symbols: D% from previous year

Geographic variations in incident ESRD patients figure 1 Geographic variations in incident ESRD patients figure 1.6, incident rate, 1990, by HSA, unadjusted Per million population 370+ (371) 300 to <370 213 to <300 156 to <213 below 156 (135)

Geographic variations in incident ESRD patients figure 1 Geographic variations in incident ESRD patients figure 1.6, incident rate, 2000, by HSA, unadjusted Per million population 370+ (452) 300 to <370 213 to <300 156 to <213 below 156 (136

Geographic variations in incident rates of ESRD patients, & in growth over time figure 1.6, 1990-1992, by HSA, unadjusted Percent change 33.3+ (45.1) 19.2 to <33.3 8.5 to <19.2 0 to <8.5 below 0 (-8.0)

Geographic variations in incident rates of ESRD patients, & in growth over time figure 1.6, 1993-1995, by HSA, unadjusted Percent change 33.3+ (44.8) 19.2 to <33.3 8.5 to <19.2 0 to <8.5 below 0 (-7.0)

Geographic variations in incident rates of ESRD patients, & in growth over time figure 1.6, 1996-1998, by HSA, unadjusted Percent change 33.3+ (45.0) 19.2 to <33.3 8.5 to <19.2 0 to <8.5 below 0 (-7.2)

Geographic variations in incident rates of ESRD patients, & in growth over time figure 1.6, 1998-2000, by HSA, unadjusted Percent change 33.3+ (42.9) 19.2 to <33.3 8.5 to <19.2 0 to <8.5 below 0 (-9.3)

Trends in median age of incident patients, by race/ethnicity figure 1 Trends in median age of incident patients, by race/ethnicity figure 1.7, incident ESRD patients

Geographic variations in prevalent rates of ESRD patients, 1990 figure 1.8, December 31 point prevalent ESRD patients, by HSA, unadjusted Per million population 1,375+ (1,393) 1,150 to <1,375 760 to <1,150 580 to <760 below 580 (506)

Geographic variations in prevalent rates of ESRD patients, 2000 figure 1.8, December 31 point prevalent ESRD pts, by HSA, unadjusted Per million population 1,375+ (1,766) 1,150 to <1,375 760 to <1,150 580 to <760 below 580 (454)

Geographic variations in prevalent rates of ESRD patients, & in growth over time: 1990-1992 figure 1.8, December 31 point prevalent ESRD pts, by HSA, unadjusted Percent change 21.3+ (28.1) 17.0 to <21.3 10.6 to <17.0 0 to <10.6 below 0 (-2.8)

Geographic variations in prevalent rates of ESRD patients, & in growth over time: 1993-1995 figure 1.8, December 31 point prevalent ESRD pts, by HSA, unadjusted (cont.) Percent change 21.3+ (27.0) 17.0 to <21.3 10.6 to <17.0 0 to <10.6 below 0 (-2.5)

Geographic variations in prevalent rates of ESRD patients, & in growth over time: 1996-1998 figure 1.8, December 31 point prevalent ESRD pts, by HSA, unadjusted Percent change 21.3+ (26.2) 17.0 to <21.3 10.6 to <17.0 0 to <10.6 below 0 (-3.3)

Geographic variations in prevalent rates of ESRD patients, & in growth over time: 1998-2000 figure 1.8, December 31 point prevalent ESRD pts, by HSA, unadjusted (cont.) Percent change 21.3+ (25.9) 17.0 to <21.3 10.6 to <17.0 0 to <10.6 below 0 (-2.7)

Trends in median age of prevalent patients, by race/ethnicity figure 1 Dialysis Transplant

Geographic variations in prevalent rates: dialysis figure 1 Geographic variations in prevalent rates: dialysis figure 1.10, 2000, by HSA, adjusted for age, gender, & race Per million population 1,070+ (1,265) 970 to <1,070 890 to <970 810 to <890 below 810 (725)

Geographic variations in prevalent rates: transplant figure 1 Geographic variations in prevalent rates: transplant figure 1.10, 2000, by HSA, adjusted for age, gender, & race Per million population 416+ (499) 372 to <416 341 to <372 309 to <341 below 309 (280)

Geographic variations in prevalent rates of dialysis patients, by race/ethnicity: white figure 1.11, December 31 point prevalent patients, 2000, by HSA, unadjusted Per million population 1,090+ (1,224) 1,010 to <1,090 930 to <1,010 870 to <930 below 870 (788)

Geographic variations in prevalent rates of dialysis patients, by race/ethnicity: black figure 1.11, December 31 point prevalent patients, 2000, by HSA, unadjusted Per million population 3,670+ (4,046) 3,380 to <3,670 3,000 to <3,380 2,580 to <3,000 below 2,580 (2,267)

Geographic variations in prevalent rates of dialysis patients, by race/ethnicity: Native American figure 1.11, December 31 point prevalent patients, 2000, by HSA, unadjusted Per million population 2,740+ (4,564) 2,000 to <2,740 1,530 to <2,000 1,210 to <1,530 below 1,210 (986)

Geographic variations in prevalent rates of dialysis patients, by race/ethnicity: Asian figure 1.11, December 31 point prevalent patients, 2000, by HSA, unadjusted Per million population 1,200+ (1,374) 1,080 to <1,200 990 to <1,080 920 to <990 below 920 (834)

Geographic variations in prevalent rates of dialysis patients, by race/ethnicity: Hispanic figure 1.11, December 31 point prevalent patients, 2000, by HSA, unadjusted Per million population 1,020+ (1,307) 840 to <1,020 700 to <840 580 to <700 below 580 (507)

Geographic variations in prevalent rates of dialysis pts, by race/ethnicity: non-Hispanic figure 1.11, December 31 point prevalent patients, 2000, by HSA, unadjusted Per million population 1,510+ (1,928) 1,250 to <1,510 1,120 to <1,250 990 to <1,120 below 990 (867)

Trends in prevalent patient counts, by modality & race/ethnicity figure 1.12, December 31, point prevalent patients Dialysis Transplant

Geographic variations in prevalent rates of dialysis patients, by race/ethnicity: 1990-2000, white figure 1.13, December 31 point prevalent patients, by HSA, unadjusted Percent change 125.0+ (152.0) 105.0 to <125.0 88.0 to <105.0 71.0 to <88.0 below 71.0 (56.0)

Geographic variations in prevalent rates of dialysis patients, by race/ethnicity: 1990-2000, black figure 1.13, December 31 point prevalent patients, by HSA, unadjusted Percent change 96.7+ (127.7) 77.9 to <96.7 62.0 to <77.9 46.3 to <62.0 below 46.3 (30.3)

Geographic variations in prevalent rates of dialysis patients, by race/ethnicity: 1990-2000, Native Am. figure 1.13, December 31 point prevalent patients, by HSA, unadjusted Percent change 211.0 (529.1) 112.5 to <211.0 65.9 to <112.5 31.6 to <65.9 below 31.6 (7.2)

Geographic variations in prevalent rates of dialysis patients, by race/ethnicity: 1990-2000, Asian figure 1.13, December 31 point prevalent patients, by HSA, unadjusted Percent change 86.3+ (126.8) 61.5 to <86.3 43.9 to <61.5 31.5 to <43.9 below 31.5 (20.0)

Geographic variations in prevalent rates of dialysis patients, by race/ethnicity: 1990-2000, Hispanic figure 1.13, December 31 point prevalent patients, by HSA, unadjusted Percent change 622+ (1,536) 510 to <622 422 to <510 361 to <422 below 361 (305)

Geographic variations in prevalent rates of dialysis patients, by race/ethnicity: 1990-2000, non-Hispanic figure 1.13, December 31 point prevalent patients, by HSA, unadjusted Percent change 124.4+ (155.1) 98.8 to <124.4 80.2 to <98.8 57.9 to <80.2 below 57.9 (37.8)

Incident patient demographics, 1990-2000 table 1 Incident patient demographics, 1990-2000 table 1.e, by primary diagnosis & first modality: column percent

Incident patient demographics, 1990-2000 table 1 Incident patient demographics, 1990-2000 table 1.e, by primary diagnosis & first modality: column percent (cont.)

Trends in incident rates, by primary diagnosis figure 1 Trends in incident rates, by primary diagnosis figure 1.14, adjusted for age, gender, race

Trends in incident rates, by race/ethnicity figure 1 Trends in incident rates, by race/ethnicity figure 1.15, adjusted for age, gender, race

Trends in incident rates, by race/ethnicity & primary diagnosis figure 1.16, adjusted for age & gender

Incident patient demographics, 1990-2000, by primary diagnosis & first modality: row percent table 1.f

Incident patient demographics, 1990-2000, by primary diagnosis & first modality: row percent table 1.f (cont.)

Geographic variations in incident rates, by primary diagnosis: diabetes, 1990 figure 1.17, by HSA, unadjusted Per million population 205+ (260) 125 to <205 57 to <125 49 to <57 below 49 (44)

Geographic variations in incident rates, by primary diagnosis: diabetes, 2000 figure 1.17, by HSA, unadjusted Per million population 205+ (245) 125 to <205 57 to <125 49 to <57 below 49 (NA)

Geographic variations in incident rates, by primary diagnosis: diabetes: 1990-2000 figure 1.17, by HSA, unadjusted Percent change 186+ (241) 148 to <186 119 to <148 90 to <119 below 90 (65)

Geographic variations in incident rates, by primary diagnosis: hypertension, 1990 figure 1.18, by HSA, unadjusted Per million population 106.1+ (119.6) 76.2 to <106.1 60.4 to <76.2 46.6 to <60.4 below 46.6 (33.8)

Geographic variations in incident rates, by primary diagnosis: hypertension, 2000 figure 1.18, by HSA, unadjusted Per million population 106.1+ (149.0) 76.2 to <106.1 60.4 to <76.2 46.6 to <60.4 below 46.6 (34.7)

Geographic variations in incident rates, by primary diagnosis: hypertension, 1990-2000 figure 1.18, by HSA, unadjusted Percent change 102.5+ (143.6) 66.7 to <102.5 44.1 to <66.7 23.0 to <44.1 below 23.0 (4.5)

Geographic variations in incident rates: IgA nephropathy/Berger’s figure 1.19, 1990-2000 combined, by HSA, unadjusted Percent of patients 1.65+ (1.82) 1.45 to <1.65 1.28 to <1.45 1.11 to <1.28 below 1.11 (0.98)

Patient distribution, by age, race, & gender: IgA nephropathy/Berger’s figure 1.20, incident ESRD patients, 1990-2000 combined

Geographic variations in incident rates: Goodpasture’s syndrome figure 1.21, incident ESRD patients, 1990-2000 combined, by HSA, unadjusted Percent of patients 0.425+ (0.50) 0.377 to <0.425 0.337 to <0.377 0.289 to <0.337 below 0.289 (0.253)

Patient distribution, by age, race, & gender: Goodpasture’s syndrome figure 1.22, incident ESRD patients, 1990-2000 combined

Geographic variations in incident rates: Lupus erythematosus (SLE nephritis) figure 1.23, incident ESRD patients, 1990-2000 combined, by HSA, unadjusted Percent of patients 3.49+ (4.64) 2.55 to <3.49 2.10 to <2.55 1.79 to <2.10 below 1.79 (1.57)

Patient distribution, by age, race, & gender: Lupus erythematosus (SLE nephritis) figure 1.24, incident ESRD patients, 1990-2000 combined

Geographic variations in incident rates: Other secondary GN/vasculitis figure 1.25, incident ESRD patients, 1990-2000 combined Percent of patients 2.12+ (2.55) 1.83 to <2.12 1.58 to <1.83 1.38 to <1.58 below 1.38 (1.22)

Patient distribution, by age, race, & gender: other secondary GN/vasculitis figure 1.26, incident ESRD patients, 1990-2000 combined

Geographic variations in incident rates: Scleroderma figure 1 Geographic variations in incident rates: Scleroderma figure 1.27, incident ESRD patients, 1990-2000 combined, by HSA, unadjusted Percent of patients 0.595+ (0.621) 0.562 to <0.595 0.541 to <0.562 0.512 to <0.541 below 0.512 (0.468)

Patient distribution, by age, race, & gender: Scleroderma figure 1 Patient distribution, by age, race, & gender: Scleroderma figure 1.28, rates adjusted for age, gender, & race

Geographic variations in incident rates: Alport’s, other hereditary/familial disease figure 1.29, incident ESRD patients, 1990-2000 combined, by HSA, unadjusted Percent of patients 0.679+ (0.809) 0.595 to <0.679 0.535 to <0.595 0.466 to <0.535 below 0.466 (0.415)

Patient distribution, by age, race, & gender: Alport’s, other hereditary/familial disease figure 1.30, rates adjusted for age, gender, & race

Geographic variations in incident rates: Multiple myeloma & light chain nephropathy figure 1.31, incident ESRD patients, 1990-2000 combined, by HSA, unadjusted Percent of patients 2.83+ (3.11) 2.60 to <2.83 2.43 to <2.60 2.16 to <2.43 below 2.16 (1.91)

Patient distribution, by age, race, & gender: Multiple myeloma & light chain nephropathy figure 1.32, rates adjusted for age, gender, & race

Geographic variations in incident rates: AIDS nephropathy figure 1 Geographic variations in incident rates: AIDS nephropathy figure 1.33, incident ESRD patients, 1990-2000 combined, by HSA, unadjusted Percent of patients 1.03+ (3.12) 0.35 to <1.03 0.22 to <0.35 0.13 to <0.22 below 0.13 (0.08)

Patient distribution, by age, race, & gender: AIDS nephropathy figure 1.34, incident ESRD patients, 1990-2000 combined, by HSA, unadjusted

Patient counts, by disease figure 1 Patient counts, by disease figure 1.35, incident ESRD patients, 1990-2000 combined * * Under-estimate of patient counts based on coding

Distribution of Hispanic patients & patients with diabetes, by ESRD network, 2000 figure 1.36

Distribution of black patients & patients with hypertension, by ESRD network, 2000 figure 1.37

Distribution of Asian patients & patients with glomerulonephritis, by ESRD network, 2000 figure 1.38

Geographic variations in mean age, by HSA & ESRD network figure 1 Geographic variations in mean age, by HSA & ESRD network figure 1.39, incident ESRD patients, 1998-2000 combined Mean age 63.6+ (64.7) 62.2 to <63.6 61.1 to <62.2 59.9 to <61.1 below 59.9 (58.8)

Geographic variations in mean age, by HSA & ESRD network figure 1 Geographic variations in mean age, by HSA & ESRD network figure 1.39, prevalent patients, 2000, by HSA, unadjusted Mean age 57.6+ (58.5) 56.7 to <57.6 56.2 to <56.7 55.3 to <56.2 below 55.3 (54.5)

Patient demographics, by ESRD network, incident dialysis patients: 2000 table 1.g

Patient demographics, by ESRD network, incident dialysis patients: 2000 table 1.g (cont.)

Patient demographics, by ESRD network, point prevalent dialysis patients: 2000 table 1.h

Patient demographics, by ESRD network, point prevalent dialysis patients: 2000 table 1.h (cont.)

Patient demographics, by ESRD network, point prevalent transplant patients: 2000 table 1.i

Patient demographics, by ESRD network, point prevalent transplant patients: 2000 table 1.I (cont.)